共 176 条
[1]
Stupp R(2009)Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 459-466
[2]
Hegi ME(2004)Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease. A study of the Spanish medical neuro-oncology group (GENOM) J Neuro-Oncol 70 359-369
[3]
Mason WP(2003)Valproate: past, present, and future CNS drug reviews 9 199-216
[4]
Balana C(2009)Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the quality standards subcommittee and therapeutics and technology assessment subcommittee of the American Academy of Neurology and American Epilepsy Society Neurology 73 133-141
[5]
Lopez-Pousa A(2007)Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management Lancet Neurol 6 421-430
[6]
Berrocal A(2001)Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen J Biol Chem 276 36734-36741
[7]
Johannessen CU(2005)Valproic acid alters chromatin structure by regulation of chromatin modulation proteins Cancer Res 65 3815-3822
[8]
Johannessen SI(2007)Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational study J Clin Oncol 25 1979-1985
[9]
Harden CL(2013)Valproic acid use during radiation therapy for glioblastoma associated with improved survival Int J Radiat Oncol Biol Phys 86 504-509
[10]
Meador KJ(2011)Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma Neurology 77 1156-1164